Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10025965rdf:typepubmed:Citationlld:pubmed
pubmed-article:10025965lifeskim:mentionsumls-concept:C0043393lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C0521451lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C0136073lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C0917877lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C1423023lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C1150298lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:10025965lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:10025965pubmed:issue3lld:pubmed
pubmed-article:10025965pubmed:dateCreated1999-3-11lld:pubmed
pubmed-article:10025965pubmed:abstractTextPreviously we reported that the R73A and H144Q variants of the yeast cyclophilin Cpr3 were virtually inactive in a protease-coupled peptide assay, but retained activity as catalysts of a proline-limited protein folding reaction [Scholz, C. et al. (1997) FEBS Lett. 414, 69-73]. A reinvestigation revealed that in fact these two mutations strongly decrease the prolyl isomerase activity of Cpr3 in both the peptide and the protein-folding assay. The high folding activities found previously originated from a contamination of the recombinant Cpr3 proteins with the Escherichia coli protein SlyD, a prolyl isomerase that co-purifies with His-tagged proteins. SlyD is inactive in the peptide assay, but highly active in the protein-folding assay.lld:pubmed
pubmed-article:10025965pubmed:languageenglld:pubmed
pubmed-article:10025965pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:citationSubsetIMlld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10025965pubmed:statusMEDLINElld:pubmed
pubmed-article:10025965pubmed:monthJanlld:pubmed
pubmed-article:10025965pubmed:issn0014-5793lld:pubmed
pubmed-article:10025965pubmed:authorpubmed-author:ScholzCClld:pubmed
pubmed-article:10025965pubmed:authorpubmed-author:SchmidF XFXlld:pubmed
pubmed-article:10025965pubmed:authorpubmed-author:MaierPPlld:pubmed
pubmed-article:10025965pubmed:authorpubmed-author:HeitmanJJlld:pubmed
pubmed-article:10025965pubmed:authorpubmed-author:DolinskiKKlld:pubmed
pubmed-article:10025965pubmed:issnTypePrintlld:pubmed
pubmed-article:10025965pubmed:day29lld:pubmed
pubmed-article:10025965pubmed:volume443lld:pubmed
pubmed-article:10025965pubmed:ownerNLMlld:pubmed
pubmed-article:10025965pubmed:authorsCompleteYlld:pubmed
pubmed-article:10025965pubmed:pagination367-9lld:pubmed
pubmed-article:10025965pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:meshHeadingpubmed-meshheading:10025965...lld:pubmed
pubmed-article:10025965pubmed:year1999lld:pubmed
pubmed-article:10025965pubmed:articleTitleR73A and H144Q mutants of the yeast mitochondrial cyclophilin Cpr3 exhibit a low prolyl isomerase activity in both peptide and protein-folding assays.lld:pubmed
pubmed-article:10025965pubmed:affiliationBiochemisches Laboratorium, Universität Bayreuth, Germany.lld:pubmed
pubmed-article:10025965pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10025965pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10025965lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10025965lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10025965lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10025965lld:pubmed